Article
PTEN inhibitor attenuates cardiac fibrosis by regulating the M2 macrophage phenotype via the PI3K/AKT/TGF-β/Smad 2/3 signaling pathway.
International journal of cardiology - 1 Jun 2022
Zhuang Chenchen, Guo Ziyi, Zhu Jumo, Wang Wenjuan, Sun Runmin, Qi Miaomiao, Wang Qiongying, Fan Xin, Ma Runxin, Yu Jing
Abstract excerpt
Cardiac fibrosis is a key feature of hypertensive cardiac remodeling. In response to microenvironmental stimuli, phenotypic and functional changes in macrophages are considered important determinants of cardiac fibrosis attenuation. VO-OHpic, a phosphatase and tension homolog of chromosome 10 (PTEN) inhibitor, has been demonstrated to be cardioprotective in cardiac remodeling. However, whether VO-OHpic can...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
